Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (827)
- Medicine suspension (472)
- Complementary medicine cancellation (203)
- Medical device suspension (86)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (51)
- Medical device cancellation - certain devices within an entry (22)
- Registered medicine cancellation (12)
- Voluntary revocation at the request of the manufacturer (9)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Medical device cancellation (1)
- Medical device cancellation – certain devices within an entry (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Results for
"[search-keyword]"
Search
1780 result(s) found, displaying 951 to 975
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 12/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 11/01/2021
-
Cancellation or suspensionRegulatory action due to Non response following a s41JA, effective 07/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 06/01/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 24/12/2020
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 24/12/2020
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular. As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(ja) of the Act was incorrect. It appeared to the Secretary that the presentation of the goods was unacceptable., effective 23/12/2020
-
Cancellation or suspensionRegulatory action due to The product is an excluded good for the purposes of the Act, that is, the product is determined not to be a therapeutic good. Therefore the certification made by the sponsor under paragraph 41FD(a) of the Act in the application for inclusion, that the product is a medical device, is incorrect., effective 18/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Non response following s41JA, effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Non response following s41JA, effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Non response following s41JA, effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2020